Gene: RMDN1
Official Full Name: regulator of microtubule dynamics 1provided by HGNC
Gene Summary: Enables microtubule binding activity. Predicted to be involved in attachment of mitotic spindle microtubules to kinetochore and mitotic spindle organization. Located in mitotic spindle pole and spindle microtubule. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23014 | RMDN1 Knockout cell line (HeLa) | Human | RMDN1 | 1:3~1:6 | Negative | Online Inquiry |
KO23015 | RMDN1 Knockout cell line (HCT 116) | Human | RMDN1 | 1:2~1:4 | Negative | Online Inquiry |
KO23016 | RMDN1 Knockout cell line (HEK293) | Human | RMDN1 | 1:3~1:6 | Negative | Online Inquiry |
KO23017 | RMDN1 Knockout cell line (A549) | Human | RMDN1 | 1:3~1:4 | Negative | Online Inquiry |
RMDN1 Gene Knockout Cell Lines are cellular models specifically engineered to disrupt the RMDN1 gene, a critical component involved in various cellular processes, including ribosome assembly and stress response pathways. This product serves as an invaluable tool for researchers studying the functional implications of RMDN1 deficiency in human cells, allowing for the exploration of its role in diseases such as cancer, neurodegeneration, and cellular aging.
The primary function of the RMDN1 Gene Knockout Cell Lines lies in their ability to facilitate targeted gene analysis through the absence of RMDN1 expression. This is achieved via CRISPR/Cas9 technology, which enables precise modifications to the genome, thereby creating a reliable platform for observing phenotypic and biochemical changes. Researchers can investigate downstream effects of RMDN1 loss, such as alterations in cell proliferation, apoptosis, and stress response mechanisms, offering insights into potential therapeutic targets.
In terms of scientific importance, these knockout cell lines represent a significant advancement in the field of molecular biology and genetics. They are particularly valuable for examining gene function and its implications in various pathologies, as well as in drug discovery and development sectors. Clinical settings benefit from these tools in translational research, as they provide a biological basis for understanding the underlying mechanisms of diseases related to RMDN1 dysfunction.
Compared to alternative cell lines, RMDN1 Gene Knockout Cell Lines are meticulously validated and characterized, ensuring consistency and reliability in experimental results. Their specificity in targeting the RMDN1 gene allows researchers to bypass off-target effects commonly encountered with less sophisticated gene-editing strategies. Furthermore, these lines are compatible with a wide range of biochemical assays, making them versatile for multifaceted research applications.
The value of RMDN1 Gene Knockout Cell Lines extends to researchers and clinicians who are seeking to elucidate the complex roles of this gene in health and disease. By utilizing this cutting-edge product, users can enhance their understanding of cellular mechanisms and potentially develop innovative therapeutic approaches.
Our company, dedicated to advancing scientific knowledge and biotechnological applications, takes pride in offering high-quality, rigorously tested biological products. Our expertise in genetics and cell biology ensures that researchers and clinicians are equipped with the tools necessary to drive impactful discoveries in their fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.